Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Local biotechnology companies in the spotlight in Europe

Local biotechnology companies in the spotlight in Europe

26 May 2014 - Two Christchurch biotechnology companies, Olympic Biotec Ltd and Waitaki Biosciences, the trading division of PharmaZen Ltd, have pooled their expertise to produce the world’s first 100% krill powder.

The Rimfrost Pristine Krill Powder was recently in the spotlight at Vitafoods Europe, Europe’s largest nutraceutical show, held in Geneva.

Rimfrost Pristine is the first 100% krill powder to be developed internationally, offering a new opportunity for international manufacturers of nutraceuticals and health supplements to extend their range of health promoting omega-3 products – with potential benefits to cardiovascular and joint health among other uses.

The two local companies worked jointly on this project over the past 12-18 months, leveraging off their respective strengths – the high-quality krill raw material of Olympic Biotec, coupled with the acknowledged manufacturing and processing capabilites of PharmaZen.

John Cameron, managing director of Olympic Biotec Ltd, said it was extremely pleasing to reach this milestone after many months of research, development and refining the manufacturing process.

”Olympic has strong expertise in fishing, the harvesting of krill and the manufacturing of high quality krill products. To develop a powder product was a further step, and we lent heavily on PharmaZen’s long experience in manufacturing powdered marine ingredients.”

PharmaZen CEO Craig McIntosh was delighted with his company’s involvement.

”Olympic Biotec identified a significant market opportunity that was a bit of a reach technically. We had a very open dialogue, bouncing concepts back and forward between the companies until we had the product finalised.”

Early feedback from the market has been extremely positive and Olympic is now developing its global strategy to meet this demand, Mr Cameron said.

Olympic Biotec is one of the fastest growing companies in New Zealand’s biotechnology sector. It achieved sales of close to $10 million in 2012, its first year of operation and more than doubled that to well over $20 million by year end 2013.

“This growth reflects the rapid growth of the international market for krill oil and the company’s ability to move quickly to secure opportunities within that sector,” Mr Cameron said.

“Our success is based on having extremely strong sales networks, the development of processing capabilities and a strong commitment to research and technical innovation.

In New Zealand, we have made large investments in a number of processing sites and have also invested heavily with research institutes both in New Zealand and overseas.”

Mr Cameron said two other Christchurch nutraceutical companies present in Geneva under-scored the strength of the local nutraceutical cluster. Aroma New Zealand and Bio-Mer were also exhibiting, while local marketer and distributor RMF Nutraceuticals also had a presence.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Sky City : Auckland Convention Centre Cost Jumps By A Fifth

SkyCity Entertainment Group, the casino and hotel operator, is in talks with the government on how to fund the increased cost of as much as $130 million to build an international convention centre in downtown Auckland, with further gambling concessions ruled out. The Auckland-based company has increased its estimate to build the centre to between $470 million and $530 million as the construction boom across the country drives up building costs and design changes add to the bill.
More>>

ALSO:

RMTU: Mediation Between Lyttelton Port And Union Fails

The Rail and Maritime Union (RMTU) has opted to continue its overtime ban indefinitely after mediation with the Lyttelton Port of Christchurch (LPC) failed to progress collective bargaining. More>>

Earlier:

Science Policy: Callaghan, NSC Funding Knocked In Submissions

Callaghan Innovation, which was last year allocated a budget of $566 million over four years to dish out research and development grants, and the National Science Challenges attracted criticism in submissions on the government’s draft national statement of science investment, with science funding largely seen as too fragmented. More>>

ALSO:

Scoop Business: Spark, Voda And Telstra To Lay New Trans-Tasman Cable

Spark New Zealand and Vodafone, New Zealand’s two dominant telecommunications providers, in partnership with Australian provider Telstra, will spend US$70 million building a trans-Tasman submarine cable to bolster broadband traffic between the neighbouring countries and the rest of the world. More>>

ALSO:

More:

Statistics: Current Account Deficit Widens

New Zealand's annual current account deficit was $6.1 billion (2.6 percent of GDP) for the year ended September 2014. This compares with a deficit of $5.8 billion (2.5 percent of GDP) for the year ended June 2014. More>>

ALSO:

Still In The Red: NZ Govt Shunts Out Surplus To 2016

The New Zealand government has pushed out its targeted return to surplus for a year as falling dairy prices and a low inflation environment has kept a lid on its rising tax take, but is still dangling a possible tax cut in 2017, the next election year and promising to try and achieve the surplus pledge on which it campaigned for election in September. More>>

ALSO:

Job Insecurity: Time For Jobs That Count In The Meat Industry

“Meat Workers face it all”, says Graham Cooke, Meat Workers Union National Secretary. “Seasonal work, dangerous jobs, casual and zero hours contracts, and increasing pressure on workers to join non-union individual agreements. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news